NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Chinook Therapeutics, Inc. (NASDAQ:KDNY) resulting from allegations that Chinook may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Chinook securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=16257 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On May 16, 2023, Muddy Waters Research issued a report on Chinook Therapeutics, Inc., alleging …
